The population level care cascade for hepatitis C in British Columbia, Canada as of 2018: Impact of direct acting antivirals

Abstract

Although gaps in HCV RNA and genotype testing after antibody diagnosis exist, the largest gap in the care cascade is treatment initiation, despite introduction of DAA treatment and removal of treatment eligibility restrictions. Further interventions are required to ensure testing and treatment is equitably accessible in BC.